A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics

Marianne Lucena da Silva,Rodrigo Santiago Barbosa Rocha,Mohamed Buheji,Haitham Jahrami,Katiane da Costa Cunha
DOI: https://doi.org/10.1177/1359105320951620
Abstract:Coronavirus pandemics causes systemic and mainly pulmonary changes. We assessed the prevalence of generalized anxiety disorder (GAD) in pandemic survivors and the general population. Papers indexed by MEDLINE/PubMed, The Cochrane, Embase, Lilacs, Scielo, Psycoinfo, and Pepsic databases were searched to April 2020, using GAD and Coronavirus (CoV) infection as keywords. Sixteen studies with 25,779 participants in eight countries were included. A 46% pooled prevalence of anxiety symptoms (95% CI 33.9-58.2%) was found with significant evidence of between-study heterogeneity (Q = 154953, I2 = 99.99%, p < 0.001). Age and sex were not found to be significant moderators for anxiety symptoms. Intervention programs for anxiety symptoms are highly recommended.
What problem does this paper attempt to address?